HLB Co., Ltd. (KOSDAQ:028300)
27,050
-700 (-2.52%)
Nov 20, 2026, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 3.6 trillion as of November 20, 2026. It is the 5,233rd most valuable company in the world and the 107th biggest in South Korea. Its market cap has decreased by 40.97% in one year.
Market Cap
3.60T
Enterprise Value
3.94T
Revenue
101.34B
Global Rank
Country Rank
#107 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 3.60T, an increase of 26,617.73%. That is a compound annual growth rate of 36.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.60T | -46.21% |
| Dec 30, 2025 | 6.69T | -30.26% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 11.92T |
| Samsung Epis Holdings | 8.83T |
| SK Biopharmaceuticals | 6.79T |
| SK bioscience | 2.97T |
| Hugel | 2.35T |
| ABL Bio | 2.09T |
| LigaChem Biosciences | 2.07T |
| Peptron | 2.03T |